BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23179556)

  • 1. Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation.
    Dai F; Zhang Y; Zhu X; Shan N; Chen Y
    Target Oncol; 2012 Dec; 7(4):217-25. PubMed ID: 23179556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer.
    Dai F; Zhang Y; Zhu X; Shan N; Chen Y
    Gynecol Oncol; 2013 Nov; 131(2):451-9. PubMed ID: 23933187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism involved in the loss of PTEN expression in NSCLC tumor cells.
    Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y
    Biochem Biophys Res Commun; 2012 Feb; 418(3):547-52. PubMed ID: 22290228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of paclitaxel resistance in epithelial ovarian carcinoma cells by a MUC1 aptamer-let-7i chimera.
    Liu N; Zhou C; Zhao J; Chen Y
    Cancer Invest; 2012 Oct; 30(8):577-82. PubMed ID: 22812695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis.
    Zheng J; Wu C; Lin Z; Guo Y; Shi L; Dong P; Lu Z; Gao S; Liao Y; Chen B; Yu F
    FEBS J; 2014 Jan; 281(1):88-103. PubMed ID: 24138392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway.
    Kumar P; Raeman R; Chopyk DM; Smith T; Verma K; Liu Y; Anania FA
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3537-3545. PubMed ID: 30293572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of DNA methylation and tumor suppression gene expression by miR-29b in leukemia patients and related mechanisms.
    Chen YL; Zhang ZX; Shou LH; Di JY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):158-165. PubMed ID: 29364483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOTAIR Epigenetically Modulates PTEN Expression via MicroRNA-29b: A Novel Mechanism in Regulation of Liver Fibrosis.
    Yu F; Chen B; Dong P; Zheng J
    Mol Ther; 2017 Jan; 25(1):205-217. PubMed ID: 28129115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
    Garzon R; Liu S; Fabbri M; Liu Z; Heaphy CE; Callegari E; Schwind S; Pang J; Yu J; Muthusamy N; Havelange V; Volinia S; Blum W; Rush LJ; Perrotti D; Andreeff M; Bloomfield CD; Byrd JC; Chan K; Wu LC; Croce CM; Marcucci G
    Blood; 2009 Jun; 113(25):6411-8. PubMed ID: 19211935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of MUC1-Aptamer Functionalized Hybrid Nanoparticles for Targeted Delivery of miRNA-29b to Nonsmall Cell Lung Cancer.
    Perepelyuk M; Sacko K; Thangavel K; Shoyele SA
    Mol Pharm; 2018 Mar; 15(3):985-993. PubMed ID: 29432024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1.
    Qin H; Zhu X; Liang J; Wu J; Yang Y; Wang S; Shi W; Xu J
    J Dermatol Sci; 2013 Jan; 69(1):61-7. PubMed ID: 23142053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Double-Negative Feedback Interaction between MicroRNA-29b and DNMT3A/3B Contributes to Ovarian Cancer Progression.
    Teng Y; Zuo X; Hou M; Zhang Y; Li C; Luo W; Li X
    Cell Physiol Biochem; 2016; 39(6):2341-2352. PubMed ID: 27832631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
    Cui H; Wang L; Gong P; Zhao C; Zhang S; Zhang K; Zhou R; Zhao Z; Fan H
    PLoS One; 2015; 10(4):e0123926. PubMed ID: 25874772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusaric acid-induced promoter methylation of DNA methyltransferases triggers DNA hypomethylation in human hepatocellular carcinoma (HepG2) cells.
    Ghazi T; Nagiah S; Naidoo P; Chuturgoon AA
    Epigenetics; 2019 Aug; 14(8):804-817. PubMed ID: 31060424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins.
    Perepelyuk M; Maher C; Lakshmikuttyamma A; Shoyele SA
    Int J Nanomedicine; 2016; 11():3533-44. PubMed ID: 27555773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-29b regulates DNA methylation by targeting Dnmt3a/3b and Tet1/2/3 in porcine early embryo development.
    Zhang Z; Cao Y; Zhai Y; Ma X; An X; Zhang S; Li Z
    Dev Growth Differ; 2018 May; 60(4):197-204. PubMed ID: 29878317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-29b restrains cholangiocarcinoma progression by relieving DNMT3B-mediated repression of CDKN2B expression.
    Cao K; Li B; Zhang YW; Song H; Chen YG; Gong YJ; Li HY; Zuo S
    Aging (Albany NY); 2021 Feb; 13(4):6055-6065. PubMed ID: 33601338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
    Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
    Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction between miR-21 and DNA methylation in different breast cancer cells].
    Zhang YY; Tian WP; Mei M
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):220-4. PubMed ID: 26387181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
    Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y
    J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.